Arylsulfonamide CCR3 antagonists
Abstract:
Provided herein are arylsulfonamides that are useful for modulating CCR3 activity, and pharmaceutical compositions thereof. Also provided herein are methods of their use for treating, preventing, or ameliorating one or more symptoms of a CCR3-mediated disorder, disease, or condition.
Public/Granted literature
Information query
Patent Agency Ranking
0/0